Occupe actuellement des postes chez Clearside Biomedical Inc and BioCryst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Clearside Biomedical Inc | 21 avril 2020 - |
Independent Director | BioCryst Pharmaceuticals Inc | 20 janvier 2012 - |
Independent Director | Cubist Pharmaceuticals LLC | 12 juin 2008 - 21 janvier 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-10-04 | 2023-10-03 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
10 000
+12.0%
0,868 600 USD |
10 000 +12.0% | 0,86 | 8 600 USD | |
2023-06-15 | 2023-06-14 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
V Vente |
12 866
-13.6%
8,04103 443 USD |
12 866 -13.6% | 8,04 | 103 443 USD | |
2022-11-21 | 2022-11-17 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
30 000
+56.6%
1,3339 900 USD |
30 000 +56.6% | 1,33 | 39 900 USD | |
2021-10-19 | 2021-10-15 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
VP Vente planifiée |
105 000
-61.7%
15,401 617 000 USD |
105 000 -61.7% | 15,40 | 1 617 000 USD | |
2021-08-17 | 2021-08-16 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
3 000
+30.0%
5,6817 040 USD |
3 000 +30.0% | 5,68 | 17 040 USD | |
2021-06-14 | 2021-06-10 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
VP Vente planifiée |
23 333
-26.4%
16,86393 394 USD |
23 333 -26.4% | 16,86 | 393 394 USD | |
2021-03-15 | 2021-03-12 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
5 000
+100.0%
3,1115 525 USD |
5 000 +100.0% | 3,11 | 15 525 USD | |
2020-05-21 | 2020-05-20 |
Clearside Biomedical Inc
(CLSD)
|
A Achat |
5 000
+inf%
1,859 250 USD |
5 000 +inf% | 1,85 | 9 250 USD | |
2018-12-17 | 2018-12-17 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
A Achat |
1 000
+inf%
4,464 460 USD |
1 000 +inf% | 4,46 | 4 460 USD |